MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-02-0036269
Incus Pharmaceuticals Private Limited - pharma in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.38 Cr
▲ 14% YoY
Net profit · FY 2025
₹12.83 Lakh
Net margin 2%
EBITDA · FY 2025
₹29.82 Lakh
EBITDA margin 4.7%
Authorised capital
₹5.1 Lakh
Registered with MCA
Paid-up capital
₹5.1 Lakh
Issued & subscribed
Open charges
₹67.29 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
About Incus Pharmaceuticals Private Limited
Data last updated:
Incus Pharmaceuticals Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 October 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2009PTC024907. Its GSTIN is 32AACCI1549M1ZK (Kerala).
The company has an authorised share capital of ₹5.1 Lakh and a paid-up capital of ₹5.1 Lakh. It is led by directors including Narayanan Priyaranjan Das (Managing Director) and Thulaseedharan Pillai Suresh Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ernakulam, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.38 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹12.83 Lakh (net margin 2%) and EBITDA of ₹29.82 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹67.29 Lakh on record.
Incus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0036269). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website incuspharma.com.
Company details
CIN U51397KL2009PTC024907
Registration Number 024907
Incorporation Date 21 October 2009
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0036269
Key People
Narayanan Priyaranjan Das Managing Director Thulaseedharan Pillai Suresh Kumar Whole-Time Director Babu Philip Whole-Time Director Recognitions & Rankings of Incus Pharmaceuticals
Contact details
Incus Pharmaceuticals Private Limited's registered office is in Ernakulam, Kerala. Its website is incuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBuliding No. Cc 48/1163A Ground Floor Deepam Road, Poonithura Village Kanayannur Taluk, Ernakulam, Kerala, India – 682019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Incus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Incus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Incus Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Incus Pharmaceuticals Private Limited, buy the company report.
Financials of Incus Pharmaceuticals Private Limited
FY 2025 filings availableIncus Pharmaceuticals Private Limited reported revenue of ₹6.38 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹6.38 Cr ▲ 14%
Net profit · FY 2025
₹12.83 Lakh margin 2%
EBITDA · FY 2025
₹29.82 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 44%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 195%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 14% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Incus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Incus Pharmaceuticals Private Limited
Incus Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thulaseedharan Pillai Suresh Kumar | Whole-Time Director | 21 Oct 2009 | 17 Years 0 Months | Current |
| Narayanan Priyaranjan Das | Managing Director | 21 Oct 2009 | 17 Years 0 Months | Current |
| Babu Philip Also directs: Tertiary Care Private Limited | Whole-Time Director | 21 Oct 2009 | 17 Years 0 Months | Current |
| Plammoottil Janardhanan Pillai Abhilash | Whole-Time Director | 08 Dec 2022 | 3 Years 10 Months | Current |
Auditor
Incus Pharmaceuticals Private Limited is audited by BSJ AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSJ AND ASSOCIATES | FY 2023 | 010560S |
Shareholding
The shareholding of Incus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Incus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹67.29 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Apr 2025 | 101116207 | Others | ₹13.8 Lakh | Open | |
| 03 Mar 2025 | 101063661 | Bank of India | ₹7.91 Lakh | Open | |
| 08 May 2024 | 100928370 | Bank of India | ₹10.27 Lakh | Open | |
| 27 Jun 2022 | 100873683 | Hdfc Bank Limited | ₹7.31 Lakh | Open | |
| 17 Oct 2019 | 100299576 | State Bank of India | ₹28 Lakh | Open |
To see the full charge records of Incus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Incus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Incus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Incus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCI1549M1ZK | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Incus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Incus Pharmaceuticals Private Limited has 7 board changes on record since 2009: 4 appointments and 3 cessations. The latest: Plammoottil Janardhanan Pillai Abhilash was appointed as Whole-Time Director on 08 Dec 2022.
AGM
Incus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 13.80 Lakh with Charge ID 101116207 was registered on 08 Apr 2025.
Charges
A charge with State Bank Of India of Rs. 28.00 Lakh registered on 17 Oct 2019 with Charge ID 100299576 was modified on 07 Apr 2025.
Filing
Incus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Bank Of India amounted to Rs. 7.91 Lakh with Charge ID 101063661 was registered on 03 Mar 2025.
Charges
A charge with Bank Of India amounted to Rs. 10.27 Lakh with Charge ID 100928370 was registered on 08 May 2024.
Appointed
Plammoottil Janardhanan Pillai Abhilash was appointed as Whole-Time Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.31 Lakh with Charge ID 100873683 was registered on 27 Jun 2022.
Charges
A charge with State Bank Of India amounted to Rs. 28.00 Lakh with Charge ID 100299576 was registered on 17 Oct 2019.
Ceased
Babu Philip ceased to be Director.
Ceased
Plammoottil Janardhanan Pillai Abhilash ceased to be Director.
Ceased
Thulaseedharan Pillai Suresh Kumar ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Incus Pharmaceuticals is an active private limited company based in Ernakulam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 October 2009 (17+ years old) and is registered under CIN U51397KL2009PTC024907.
Incus Pharmaceuticals has 4 current directors:
- Narayanan Priyaranjan Das - Managing Director
- Thulaseedharan Pillai Suresh Kumar - Whole-Time Director
- Babu Philip - Whole-Time Director
- Plammoottil Janardhanan Pillai Abhilash - Whole-Time Director
The latest financial statements of Incus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Incus Pharmaceuticals is 32AACCI1549M1ZK, registered in Kerala.
The CIN (Corporate Identification Number) of Incus Pharmaceuticals is U51397KL2009PTC024907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incus Pharmaceuticals was incorporated on 21 October 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ernakulam.
Plammoottil Janardhanan Pillai Abhilash was appointed as Whole-Time Director on 08 Dec 2022. Babu Philip ceased to be Director on 29 Feb 2016. Plammoottil Janardhanan Pillai Abhilash ceased to be Director on 29 Feb 2016. Incus Pharmaceuticals has 7 board changes on record in total.
Yes, Incus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0036269).
Incus Pharmaceuticals can be reached through the website incuspharma.com. Its registered office is in Ernakulam, Kerala, India.
The registered office of Incus Pharmaceuticals is at Buliding No. Cc 481163A Ground Floor Deepam Road, Poonithura Village Kanayannur Taluk, Ernakulam, Kerala, India – 682019.